Rep. James R. Baird

Maddy summaryHR 828, the TROOP Act, allows service members involuntarily separated from the military solely for refusing a COVID-19 vaccine to request reinstatement to their previous rank and grade. It requires the military to provide back pay for the period between separation and reinstatement upon such a request. The bill specifically applies to individuals separated "solely" due to vaccine refusal, as defined in the legislation. It does not create new requirements for vaccination but addresses past separations by restoring pay and status.

Prohibition of Agricultural Land for the People's Republic of China Act This bill requires the President to prohibit nonresident aliens, foreign businesses, and agents associated with China's government from (1) purchasing agricultural (including ranching) real estate located in the United States, or (2) participating in Department of Agriculture programs that are unrelated to food and safety regulatory requirements.

This resolution states that the House of Representatives condemns the February 1, 2021, military coup in Burma (Myanmar) and denounces the Burmese military for human rights violations. The resolution calls on the Burmese military to end violence against prodemocracy activists and release political prisoners.

Maddy summaryHR 735 (Susan Muffley Act of 2023) requires the Pension Benefit Guaranty Corporation (PBGC) to recalculate and increase monthly pension benefits for participants and beneficiaries in six specific Delphi-related pension plans to their full vested amount. This includes making lump-sum payments for past underpayments, plus 6% annual interest on amounts owed since prior benefit calculations. The bill directly affects eligible retirees and beneficiaries in the Delphi Hourly-Rate Employees Pension Plan, Delphi Retirement Program for Salaried Employees, and four other Delphi pension plans. It does not change existing asset allocations but ensures payments reflect the full pension amount guaranteed under ERISA without prior phase-in limits.

Maddy summaryHR 683 (PASS Act of 2023) expands the Committee on Foreign Investment in the United States (CFIUS) review process to cover foreign investments in U.S. agriculture businesses, agricultural biotechnology, and private farmland. It mandates that the President block transactions involving foreign entities from China, Russia, Iran, or North Korea that would give them control over U.S. agricultural operations or land used for farming. The bill allows limited presidential waivers for national security reasons but requires a 30-day review period before any waiver. Additionally, it requires the Secretary of Agriculture to submit biannual reports to Congress on risks posed by foreign ownership in U.S. agriculture.

Disaster Reforestation Act This bill sets forth a special rule for the tax deduction for casualty losses of uncut timber (including pre-merchantable timber). It provides that in losses of any uncut timber from fire, storm, insects, invasive species, drought, or other casualty, or from theft, the basis for determining the amount of the deduction for such loss shall not be less than the excess of the value of such timber determined immediately before such loss was sustained, over the salvage value of such timber. To be eligible for the casualty loss deduction, the uncut timber subject to the loss must be reforested not later than the close of the five-year period beginning on the date of the loss.

This resolution recognizes and appreciates the dedication and devotion demonstrated by the men and women of law enforcement. It also condemns calls to defund, disband, dismantle, or abolish the police.

Protecting Life and Taxpayers Act of 2023 This bill requires federally funded entities to certify that they will not, subject to certain exceptions, perform abortions or provide funding to other entities that perform abortions. The bill provides exceptions for abortions (1) in cases of rape or incest; or (2) when the life of the woman is in danger due to a physical disorder, injury, or illness.

This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits any similar changes in the future.

Maddy summaryThis bill prohibits federal funding to Planned Parenthood Federation of America and its affiliates for one year unless they certify they won't perform or fund abortions (with exceptions for rape/incest or life-threatening conditions). It redirects $235 million in existing funding to community health centers for women's health services like contraception, cancer screenings, and prenatal care. The bill explicitly states that redirected funds will continue to support all women's health services previously provided by Planned Parenthood. It also requires repayment of funds if Planned Parenthood violates the certification, and clarifies that overall federal funding for women's health services remains unchanged.